Evaluating the EMPEROR-Preserved Risk Model and Outcomes: Insights from the FINEARTS-HF Trial
Heart failure with preserved ejection fraction (HFpEF) remains a formidable challenge for cardiologists worldwide, lacking definitive therapeutic strategies to improve ...
